These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36127156)

  • 1. Predictors for inappropriate proton pump inhibitor use: observational study in primary care.
    Koggel LM; Lantinga MA; Büchner FL; Drenth JPH; Frankema JS; Heeregrave EJ; Heringa M; Numans ME; Siersema PD
    Br J Gen Pract; 2022 Dec; 72(725):e899-e906. PubMed ID: 36127156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks.
    Soubra L; Issa M
    Int J Pharm Pract; 2019 Aug; 27(4):386-392. PubMed ID: 30942513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors.
    Craig DG; Thimappa R; Anand V; Sebastian S
    QJM; 2010 May; 103(5):327-35. PubMed ID: 20211846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization.
    Thomas L; Culley EJ; Gladowski P; Goff V; Fong J; Marche SM
    J Manag Care Pharm; 2010 Mar; 16(2):122-9. PubMed ID: 20178397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overuse of proton pump inhibitors for stress ulcer prophylaxis in Jordan.
    Alqudah MA; Al-Azzam S; Alzoubi K; Alkhatatbeh M; Rawashdeh N
    Int J Clin Pharmacol Ther; 2016 Aug; 54(8):597-602. PubMed ID: 27125772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.
    Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S
    World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Utility and Budget Impact Analysis for Stopping the Inappropriate Use of Proton Pump Inhibitors After Cessation of NSAID or Low-Dose Acetylsalicylic Acid Treatment.
    Chau SH; Sluiter RL; Hugtenburg JG; Wensing M; Kievit W; Teichert M
    Drugs Aging; 2020 Jan; 37(1):67-74. PubMed ID: 31560115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System.
    Mafi JN; May FP; Kahn KL; Chong M; Corona E; Yang L; Mongare MM; Nair V; Reynolds C; Gupta R; Damberg CL; Esrailian E; Sarkisian C
    J Am Geriatr Soc; 2019 Dec; 67(12):2600-2604. PubMed ID: 31486549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.
    Liu Y; Zhu X; Li R; Zhang J; Zhang F
    BMJ Open; 2020 Nov; 10(11):e040473. PubMed ID: 33243802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHORT COMMUNICATION-Inappropriate use of proton pump inhibitor for stress ulcer prophylaxis in a tertiary care hospital in Karachi, Pakistan.
    Samar R; Ali SA; Samar V; Mushtaq MZ; Humayun A
    Pak J Pharm Sci; 2021 Nov; 34(6):2253-2255. PubMed ID: 35034888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
    Moriarty F; Bennett K; Cahir C; Fahey T
    J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department.
    Bez C; Perrottet N; Zingg T; Leung Ki EL; Demartines N; Pannatier A
    J Eval Clin Pract; 2013 Apr; 19(2):374-8. PubMed ID: 22420909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients.
    Meli M; Raffa MP; Malta R; Morreale I; Aprea L; D'Alessandro N
    Int J Clin Pharm; 2015 Dec; 37(6):1152-61. PubMed ID: 26319396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.
    Hedberg J; Sundström J; Thuresson M; Aarskog P; Oldgren J; Bodegard J
    J Intern Med; 2013 Oct; 274(4):371-80. PubMed ID: 23800296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation.
    Giannini EG; Crespi M; Djahandideh A; Demarzo MG; Moscatelli A; Bodini G; Furnari M; Marabotto E; Plaz Torres MC; Zentilin P; Savarino V
    Dig Liver Dis; 2020 Aug; 52(8):862-868. PubMed ID: 32505566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrénées region.
    Conte C; Bourrel R; Despas F; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2019 Jun; 33(3):327-338. PubMed ID: 30625254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.